Use of direct-acting antivirals (DAAs) in people who inject drugs (PWID) has increased markedly in the era of unrestricted access to the drugs, however uptake remains suboptimal at just 38%. An observational cohort study of 853 PWID from 16 community-based sites in NSW and Queensland found 45% had detectable HCV RNA on enrolment, consistent with ...
DAA uptake improves but new strategies needed in PWID
By Mardi Chapman
21 Nov 2019